These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19660813)

  • 1. Augmenting DAF levels in vivo ameliorates experimental autoimmune encephalomyelitis.
    Li Q; Huang D; Nacion K; Bu H; Lin F
    Mol Immunol; 2009 Sep; 46(15):2885-91. PubMed ID: 19660813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production.
    Liu J; Lin F; Strainic MG; An F; Miller RH; Altuntas CZ; Heeger PS; Tuohy VK; Medof ME
    J Immunol; 2008 May; 180(9):5882-9. PubMed ID: 18424707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICOS deficiency results in exacerbated IL-17 mediated experimental autoimmune encephalomyelitis.
    Galicia G; Kasran A; Uyttenhove C; De Swert K; Van Snick J; Ceuppens JL
    J Clin Immunol; 2009 Jul; 29(4):426-33. PubMed ID: 19291374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A distinct role of CD4+ Th17- and Th17-stimulated CD8+ CTL in the pathogenesis of type 1 diabetes and experimental autoimmune encephalomyelitis.
    Ankathatti Munegowda M; Deng Y; Chibbar R; Xu Q; Freywald A; Mulligan SJ; van Drunen Littel-van den Hurk S; Sun D; Xiong S; Xiang J
    J Clin Immunol; 2011 Oct; 31(5):811-26. PubMed ID: 21674137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
    Isaksson M; Ardesjö B; Rönnblom L; Kämpe O; Lassmann H; Eloranta ML; Lobell A
    Eur J Immunol; 2009 Oct; 39(10):2925-35. PubMed ID: 19637225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
    Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H
    J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity.
    Dunn SE; Bhat R; Straus DS; Sobel RA; Axtell R; Johnson A; Nguyen K; Mukundan L; Moshkova M; Dugas JC; Chawla A; Steinman L
    J Exp Med; 2010 Aug; 207(8):1599-608. PubMed ID: 20624891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells.
    Kalantari T; Karimi MH; Ciric B; Yan Y; Rostami A; Kamali-Sarvestani E
    Clin Exp Immunol; 2014 May; 176(2):180-9. PubMed ID: 24387596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-β regulates dendritic cell activation and migration in experimental autoimmune encephalomyelitis.
    Pennell LM; Fish EN
    Immunology; 2017 Nov; 152(3):439-450. PubMed ID: 28646573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
    Mony JT; Khorooshi R; Owens T
    Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of an autoimmune model for multiple sclerosis in Th2-biased GATA3 transgenic mice.
    Fernando V; Omura S; Sato F; Kawai E; Martinez NE; Elliott SF; Yoh K; Takahashi S; Tsunoda I
    Int J Mol Sci; 2014 Jan; 15(2):1700-18. PubMed ID: 24463292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
    Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
    J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines.
    Lees JR; Iwakura Y; Russell JH
    J Immunol; 2008 Jun; 180(12):8066-72. PubMed ID: 18523270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis.
    Kohm AP; Carpentier PA; Anger HA; Miller SD
    J Immunol; 2002 Nov; 169(9):4712-6. PubMed ID: 12391178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of Notch1 in murine myeloid cells attenuates the development of experimental autoimmune encephalomyelitis by affecting Th1 and Th17 priming.
    Fernández M; Monsalve EM; López-López S; Ruiz-García A; Mellado S; Caminos E; García-Ramírez JJ; Laborda J; Tranque P; Díaz-Guerra MJM
    Eur J Immunol; 2017 Dec; 47(12):2090-2100. PubMed ID: 28762472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.
    Wan X; Pei W; Zhang Y; Zhang L; Shahzad KA; Xu T; Shen C
    Immunol Invest; 2018 Jan; 47(1):1-17. PubMed ID: 28872930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MOG(35-55) i.v suppresses experimental autoimmune encephalomyelitis partially through modulation of Th17 and JAK/STAT pathways.
    Jiang Z; Li H; Fitzgerald DC; Zhang GX; Rostami A
    Eur J Immunol; 2009 Mar; 39(3):789-99. PubMed ID: 19224632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.
    Hirata S; Senju S; Matsuyoshi H; Fukuma D; Uemura Y; Nishimura Y
    J Immunol; 2005 Feb; 174(4):1888-97. PubMed ID: 15699115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.